Advance your trials with our expertise, customized and focused for various therapeutic areas spanning large drug disease markets along with growing areas of R & D innovation.
At every stage of the drug development process, Fervor deploys the expertise you need to design, plan and execute your clinical programs with exceptional skills, precision and unwavering focus on quality
© 2021- 23. Fervor Health Solutions. All Rights Reserved.
With number of biologics going off and patent increases, biosimilar medicines are promising future for healthcare fraternity by providing greater choice and a more cost-effective alternative. Choose the right target molecule and optimal R&D strategy for developing biosimilars with Fervor’s fully integrated approach.
Extensive experience in cardiovascular clinical research trials At present, significant unmet need within select cardiovascular/metabolic (CVM) disorders is unceasing and R& D for drugs and devices is directly proportional to cost. With our cost effective and time efficient expertise, we offer end to end data driven strategies focusing your mission and unmet needs.
Demystify the complex Clinical understanding of neurobiology is never ending with highest failure rate amongst all. Unique challenges including placebo response, soft endpoints and focus on reducing patient burden is primary. Minimize development risk and maximize success probability with Fervor with applied niche technology and innovations and real time data quality monitoring and analysis
Adept to challenges and speed up program Fraught with challenges including volatility of patient health, fast interdepartmental communication at sites, elevated mortality rates and consent concerns, critical care is on high stakes. Anticipate the expectations of local IRBs and IECs and plan for informed consent challenges with strategies. With our relationships with key opinion leaders, access global network of seasoned critical care investigators and sites.
Compliant expertise with scientific acumen Patient-centric solutions, cutting-edge counsel and enterprise-wide centers of excellence yielding transformative insights and applied market impact. Advance your program and help inspire patient-centric solutions with us. Rely on our expertise to select the appropriate disease-specific assessments, imaging and scales ensuring the quality of data and integration into electronic data capture (EDC) systems.
Specialized in Phase I to IV studies, we bring a diverse range of therapies to an equally diverse range of markets, delivering projects ranging from strategic clinical development planning to single- or multi-phase clinical programs. Our close association with gastroenterologists, hepatologists, primary care investigators and KOLs across the globe ensures that the strategies developed for you are built on the best network and knowledge in the business.
Increase opportunities to develop devices and diagnostics with our tailored strategy for your global expansion With Advanced medical technologies and wealth of USFDA, EUMDR, industry, and healthcare expertise, we support you to bring safer and compliant products. Selective insights, resources and solutions for your product lifecycle ensures best market access worldwide.
Fervor has conducted diabetes trials in all global regions and has experience in running studies in emerging regions such as Eastern Europe, India and Southeast Asia where there are large pools of Type I and Type II diabetes patients. Our global approach, regional offices network and strong relationships with sites ensures high rates of patient enrolment and retention. Our clinical trial experience includes diabetes, obesity, dyslipidemia, and metabolic syndrome.
Significant experience in the designing, planning, and execution of Phase I-IV full service global trials. Our global investigator network of nephrologists, critical care specialists, endocrinologists, KOLs, academic sites and dialysis centers enable us to provide robust feasibility and consulting services across a wide spectrum of renal disease indications. Fervor’s comprehensive team across varying therapeutic areas including metabolic, cardiovascular, and autoimmune provides strategic guidance and address the challenges associated ensures Wholistic patient care.
Gain a competitive advantage for your clinical program in the ever-evolving landscape of Oncology and Hematology clinical development. With our focused approach right from developing successful strategies and end to end conduct, we navigate global regulatory landscapes to expedite approvals. Fervor has the medical leadership, hematology and oncology trained staff, global trial experience, and vast network of sites to make study a success.
Advance your ocular therapies with us to offer personalized ophthalmic drug development services spanning the entire continuum from discovery and preclinical to clinical trials and post-market follow-up studies. Work with renowned vision scientists as part of our exclusive 30+ year relationship with Fervor expertise to handle your preclinical ocular needs and deliver specialized expertise in the ocular surface and anterior and posterior segments. Enable intelligent patient recruitment with advanced data and increase your efficiencies with our established relationships with sites globally
Clinical development in a pediatric population demands both a thorough medical understanding of the disease, as well as experience working with this vulnerable and special patient population. Pediatric trials involve unique challenges including recruiting, inclusion/exclusion criteria, subject compliance, and retention. Additional complexity of family dynamics, legal status, and requirements of informed consent and assent are unique and unavoidable. Fervor understands unique concerns such as complex regulatory requirements, ethics committees’ concerns, investigators and parents associated aspects concerns for hassle free study completion
Proven expertise in radiation oncology, radiation device, and radiopharmaceutical clinical trials. Our radiation group has a consistent track record of success as a full-service CRO that can ensure flexibility to adapt to the unique needs of each radiation clinical trial. Consistent oversight by medical monitors and physicists, ensure that our sponsor’s trials are executed to their specifications throughout the life cycle of the study. Our in-house experts are board-certified radiation oncologists, radiologists, radiation physicists, and dosimetrists who are embedded within the research project team provide knowledgeable training to sites and help mitigate challenges
Need to recruit a variety of patient populations with complex diagnoses and comorbidities incites high costs and inadequate patient recruitment. Knowing your unique challenges, streamlining and simplifying through our collaborative teams and the latest technology, we provide one-stop clinical development services for you world-wide. Our expertise is not only in recruiting patient populations, but also in retaining them for long-term research, which is critical for advancing a seamless and integrated clinical research